MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neubiorev.2019.09.023

Медицинская библиотека · Neuroscience and biobehavioral reviews · 2019

Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.

Krinzinger Helga, Hall Charlotte L, Groom Madeleine J, Ansari Mohammed T, Banaschewski Tobias, Buitelaar Jan K, Carucci Sara, Coghill David, Danckaerts Marina, Dittmann Ralf W, Falissard Bruno, Garas Peter, Inglis Sarah K, Kovshoff Hanna, Kochhar Puja, McCarthy Suzanne, Nagy Peter, Neubert Antje, Roberts Samantha, Sayal Kapil, Sonuga-Barke Edmund, Wong Ian C K, Xia Jun, Zuddas Alessandro, Hollis Chris, Konrad Kerstin, Liddle Elizabeth B, ADDUCE Consortium

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод в очереди

Аннотация

Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity Disorder (ADHD) in many countries, is often prescribed for long periods of time. Any long-term psychotropic treatment in childhood raises concerns about possible adverse neurological and psychiatric outcomes. We aimed to map current evidence regarding neurological and psychiatric outcomes, adverse or beneficial, of long-term MPH (> 1 year) treatment in ADHD. We coded studies using a "traffic light" system: Green: safe/favours MPH; Amber: warrants caution; Red: not safe/not well-tolerated. Un-categorisable study findings were coded as "Unclear". Although some evidence suggests an elevated risk of psychosis and tics, case reports describe remission on discontinuation. Several studies suggest that long-term MPH may reduce depression and suicide in ADHD. Evidence suggests caution in specific groups including pre-school children, those with tics, and adolescents at risk for substance misuse. We identified a need for more studies that make use of large longitudinal databases, focus on specific neuropsychiatric outcomes, and compare outcomes from long-term MPH treatment with outcomes following shorter or no pharmacological intervention.

Для цитирования: Krinzinger Helga, Hall Charlotte L, Groom Madeleine J, Ansari Mohammed T, Banaschewski Tobias, Buitelaar Jan K, Carucci Sara, Coghill David, Danckaerts Marina, Dittmann Ralf W, Falissard Bruno, Garas Peter, Inglis Sarah K, Kovshoff Hanna, Kochhar Puja, McCarthy Suzanne, Nagy Peter, Neubert Antje, Roberts Samantha, Sayal Kapil, Sonuga-Barke Edmund, Wong Ian C K, Xia Jun, Zuddas Alessandro, Hollis Chris, Konrad Kerstin, Liddle Elizabeth B, ADDUCE Consortium. Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.. Neuroscience and biobehavioral reviews. 2019. DOI: 10.1016/j.neubiorev.2019.09.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.